Aciphex sodium

<b>ACIPHEX</b> Reimbursement for Heathcare Professionals

ACIPHEX Reimbursement for Heathcare Professionals Eisai has partnered with Rx Outreach to provide medications at low cost to financially needy patients who meet program elibility criteria. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. Get reimbursement and insurance information for ACIPHEX rabeprazole sodium Delayed-Release Tablets provided by Eisai for healthcare professionals.

FDA approves first generic versions of

FDA approves first generic versions of Indicated for short-term (up to 4 weeks) treatment in healing and symptomatic relief of duodenal ulcers 20 mg PO q Day after morning meal for up to 4 weeks; to achieve healing, some patients may require additional therapy In combination with amoxicillin and clarithromycin for treatment of H pylori infection and duodenal ulcer disease (active or history within past 5 yr) 20 mg PO BID for 7 days with morning and evening meals; take with amoxicillin 1000 mg PO BID and clarithromycin 500 mg BID Agitation Agranulocytosis Alopecia Anemia Angioedema Chest pain Delirium Erythema Hypokalemia Hypomagnesemia Hyponatremia Jaundice Leukocytosis Leukopenia Mraine Osteoporosis related fracture Rhabdomyolysis Stevens-Johnson syndrome Sudden death Toxic epidermal necrolysis Abnormal taste PPIs are possibly associated with increased incidence of Clostridium difficile-associated diarrhea (CDAD); consider diagnosis of CDAD for patients taking PPIs with diarrhea that does not improve Liver disease: May require dosage reduction Cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) reported with PPIs; avoid using for longer than mediy indicated; discontinue if sns or symptoms consistent with CLE or SLE are observed and refer patient to specialist Use of proton pump inhibitors may increase risk of salmonella and campylobacter infection Reduce of symptoms does not eliminate presence of gastric malnancy Published observational studies suggest that PPI therapy may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine; particularly with prolonged (1 yr), hh-dose therapy Decreased gastric acidity increases serum chromogranin A (Cg A) levels and may cause false positive diagnostic results for neuroendocrine tumors; temporarily discontinue PPIs before assessing Cg A levels Hypomagnesemia may occur with prolonged use (ie, 1 yr); adverse effects, such as tetany, arrhythmias, or seizures, may result; in 25% of cases reviewed, magnesium supplementation alone did not improve low serum magnesium levels, and the PPI had to be discontinued Monitor for increases in INR and prothombin time when coadministered with warfarin Daily long-term use (e.g., longer than 3 years) may lead to malabsorption or a deficiency of cyanocobalamin Acute interstitial nephritis reported in patients taking proton pump inhibitors Concomitant use of proton pump inhibitors with methotrexate, primarily at hh dose, may elevate and prolong serum concentrations of methotrexate and/or its metabolite, possibly leading to methotrexate toxicities; in hh-dose methotrexate administration, a temporary withdrawal of the PPI may be considered in some patients Metabolism: Liver; extensively by hepatic P450 enzyme CYP2C19; second pathway through CYP3A4; also by non-enzymatic reduction Metabolites (presumed inactive): Rabeprazole thioether, sulfone metabolite, desmethyl metabolite, desmethyl thioether, thioether carboxylic acid CYP2C19 substrate (minor) The above information is provided for general informational and educational purposes only. The U. S. Food and Drug Administration today approved the first generic versions of Aciphex rabeprazole sodium delayed-release tablets, used to treat.

<em>Aciphex</em> Rabeprazole <em>Sodium</em> Side

Aciphex Rabeprazole Sodium Side Rabeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Learn about Aciphex Rabeprazole Sodium may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Flamel Technologies

Flamel Technologies RABEPRAZOLE prevents the production of acid in the stomach. Flamel Technologies is a specialty pharmaceutical company, with exclusive drug delivery platforms, developing safer, improved controlled release formulation of.

Buy <em>Aciphex</em> Rabeprazole <em>Sodium</em> online without prescription

Buy Aciphex Rabeprazole Sodium online without prescription It is used to treat gastroesophageal reflux disease (GERD), certain ulcers, inflammation of the esophagus, and Zollinger-Ellison Syndrome. Aciphex belongs to a of proton pump inhibitors that reduce the amount of acid in the stomach. It is frequently used to treat GERD gastro esophageal reflux.

Drug Search Results

Drug Search Results Please note as of 01/01/2017 Flamel Technologies, Eclat Pharmaceuticals, FSC Pediatrics became Avadel. PDR provides the following FDA-approved services, including full prescribing information, drug summaries, FDA Early Warning Communications, FDA Drug Safety.


Erosive or ulcerative gastroesophageal reflux disease (GERD)Adults: 20 mg P. Rabeprazole sodium. Provides information for a treatment for heartburn as a result of erosive GERD.

<em>Aciphex</em> Rabeprazole <em>Sodium</em> Drug

Aciphex Rabeprazole Sodium Drug It works by decreasing the amount of acid your stomach makes. Learn about drug side effects and interactions for the drug Aciphex Rabeprazole Sodium.

<strong>AcipHex</strong> rabeprazole dosing, indications, interactions, adverse.

AcipHex rabeprazole dosing, indications, interactions, adverse. Rabeprazole sodium (Aciphex) is a drug used to treat gastroesophageal reflux disease, or GERD, which is a common destive problem. Medscape - Gastroesophageal reflux disease, duodenal ulcers, Helicobacter pylori eradication-specific dosing for AcipHex rabeprazole, frequency-based.


Aciphex sodium:

Rating: 95 / 100

Overall: 96 Rates